[PDF][PDF] Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK

QJ Wang, H Wang, K Pan, YQ Li, LX Huang… - … J Cancer, 2010 - researchgate.net
Comparative study on antitumor immune response of autologous cytokineinduced killer (CIK)
cells, … collected from one patient with renal cancer, two patients with lung cancer, and one …

[PDF][PDF] Correlation of HER2/neu gene amplification and protein expression with the prognosis of advanced gastric cancer patients

Y Song, J Huang, JW Wang - Chin J Cancer, 2010 - scholar.archive.org
… therapeutic field of gastric cancer has been further confirmed by prospective comparative
studies. TOGA BO18255 trial revealed that, for the advanced gastric cancer patients with HER2/…

[PDF][PDF] Radiomics in predicting tumor molecular marker P63 for non-small cell lung cancer

Q Gu, Z Feng, X Hu, M Ma, MM Jumbe… - Zhong Nan Da Xue …, 2019 - researchgate.net
… , requiring large sample, multi-center studies to further confirm the results. Secondly, this
study did not include other relatively rare lung cancer pathology types. Thirdly, the samples …

[PDF][PDF] Invasion and metastasis significance of serum MMP-9 in lung cancer patients

LJ Zhu, L Cheng, N Sun, PF Hou - … in Pharmaceutical Research, 2017 - core.ac.uk
… 9 forbreast and non-small cell lung cancer patients' sur vival [J]… in pathologic stage IA
non-small cell lung cancer [J]. J Surg … -9 in patients with resected Non small cell lung cancer[J]. J …

Comparative study of lobaplatin and cisplatin combined with etoposide for advanced small cell lung cancer/依托泊苷联合洛铂或顺铂治疗广泛期小细胞肺癌的对照研究

C Tian-jun, G Fei, SUN Zhong-min… - Xi'an jiao tong da …, 2013 - search.proquest.com
… etoposide (EL) and cisplatin plus etoposide (EP) for advanced small cell lung cancer (SCLC).
Methods: A total of 46 patients with advanced SCLC were randomized into EL group (23 …

Effect of Feitai Capsule (肺泰胶囊) on quality of life and progression-free survival of patients with unresectable non-small cell lung cancer

Z Yu, Z Liu, X Ouyang, J Du, X Dai, X Chen… - Chinese journal of …, 2012 - Springer
… A comparative analysis indicated a positive correlation (r=0.917, P<0.001). Compared with
the control group, QOL in the treatment group was significantly improved, except in the social/…

[引用][C] … Meta-Analysis of the Efficacy and Safety of Recombinant Human Vascular Endostatin Combined With Cisplatin in the Treatment of Non-Small Cell Lung Cancer …

Z Zhao, Y Yang, X Wang, W Zhou, Z Wang - Asian Case Rep Oncol, 2018

[引用][C] The value analysis of blood brain barrier permeability in the treatment of multiple brain metastases patients with non-small cell lung cancer

Z Yongli, D Jigang, L Bo, L Maojiang, C Yan… - J. Mod. Oncol, 2017

[引用][C] A systematic review of radiofrequency ablation combined with radiotherapy or chemother-apy in the treatment of advanced non-small cell lung cancer

Y Wei, Z Li, D Mi, Z Wen, Z Li - Modern Oncol, 2015

[引用][C] Efficacy of gefitinib, erlotinib and icotinib in advanced non-small cell lung cancer (NSCLC) with EGFR mutation

RN Cong, F Gu, B Wang - J Mod Oncol, 2018